1,148 filings
S-1
AIM
AIM ImmunoTech Inc
IPO registration
19 Apr 24
5:01pm
10-K
2023 FY
AIM
AIM ImmunoTech Inc
Annual report
29 Mar 24
9:18pm
4
Iii Peter W. Rodino
27 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
1:54pm
4
Equels Thomas K.
27 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
1:52pm
4
Nancy Bryan
22 Mar 24
AIM ImmunoTech / NANCY BRYAN ownership change
1:30pm
4
vkz74x edaim0umi
18 Mar 24
AIM ImmunoTech / STEWART APPELROUTH ownership change
3:01pm
4
qwnxpph6dndq fmz
18 Mar 24
AIM ImmunoTech / Thomas K Equels ownership change
3:01pm
4
lz1 0xy9t
18 Mar 24
AIM ImmunoTech / Peter W Rodino III ownership change
3:01pm
D/A
tfzbehn9hltf
21 Feb 24
$3.30 mm in debt, sold $3.30 mm, 1 investor
10:37am
D
mw24evidjt5dg5037hyc
20 Feb 24
Exempt offering of security
4:34pm
8-K
hhy1ga7ga2ah2 vsp
20 Feb 24
Entry into a Material Definitive Agreement
4:31pm
8-K
mrr1ju
9 Feb 24
AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
3:47pm
8-K
yoxybngp
25 Jan 24
Regulation FD Disclosure
5:00pm
8-K
u7a64ww 2hu7rh
10 Jan 24
Submission of Matters to a Vote of Security Holders
1:42pm
8-K
uw5gkkbo8 8r
10 Jan 24
AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating
8:45am
SC 13D/A
l4j43ol2t
3 Jan 24
AIM ImmunoTech / Deutsch Todd ownership change
4:24pm
DFAN14A
j9yyxvkwchnjmq
3 Jan 24
Additional proxy materials by non-management
4:24pm
DEFA14A
osy 7dzup0
29 Dec 23
Additional proxy soliciting materials
8:15am
DEFA14A
kbyq0aw3s01
28 Nov 23
Additional proxy soliciting materials
4:54pm
4
ouxr gjmjwa
27 Nov 23
AIM ImmunoTech / Thomas K Equels ownership change
12:56pm